Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis
Journal of Clinical Medicine · 27.12.2023 · 13 (1) · 150
DOI: 10.3390/jcm13010150 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.12.2023. Verfasst von Giuseppe Uccello und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Alessandro Manzoni Hospital-ASST Lecco, 23900 Lecco, Italy. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acute myocarditis covers a wide spectrum of clinical presentations, from uncomplicated myocarditis to severe forms complicated by hemodynamic instability and ventricular arrhythmias; however, all these forms are characterized by acute myocardial inflammation. The term “chronic inflammatory cardiomyopathy” describes a persistent/chronic inflammatory condition with a clinical phenotype of dilated and/or hypokinetic cardiomyopathy associated with symptoms of heart failure and increased risk for arrhythmias. A continuum can be identified between these two conditions. The importance of early diagnosis has grown markedly in the contemporary era with various diagnostic tools available. While cardiac magnetic resonance (CMR) is valid for diagnosis and follow-up, endomyocardial biopsy (EMB) should be considered as a first-line diagnostic modality in all unexplained acute cardiomyopathies complicated by hemodynamic instability and ventricular arrhythmias, considering the local expertise. Genetic counseling should be recommended in those cases where a genotype–phenotype association is suspected, as this has significant implications for patients’ and their family members’ prognoses. Recognition of the pathophysiological pathway and clinical “red flags” and an early diagnosis may help us understand mechanisms of progression, tailor long-term preventive and therapeutic strategies for this complex disease, and ultimately improve clinical outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Alessandro Manzoni Hospital-ASST Lecco, 23900 Lecco, Italy.
- Division of Cardiology, Tor Vergata University Hospital, 00133 Rome, Italy.
- Department of Cardiology, University Hospital of Zurich, 8091 Zurich, Switzerland.
- Inherited Cardiovascular Diseases Unit, Barts Heart Centre, St. Bartholomew's Hospital, London EC1A 7BS, UK.
- Cardiomyopathy Unit, Careggi University Hospital, 50134 Florence, Italy.
- Arrhythmia and Electrophysiology Unit, Careggi University Hospital, 50134 Florence, Italy.
ORCID-Profile: Giuseppe Uccello, Giacomo Bonacchi, Giulia Montrasio, Matteo Beltrami
Zitieren
APA
Uccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M. (2023). Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis. Journal of Clinical Medicine, 13(1), 150. https://doi.org/10.3390/jcm13010150
Vancouver
Uccello G, Bonacchi G, Rossi VA, Montrasio G, Beltrami M. Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis. Journal of Clinical Medicine. 2023;13(1):150. doi:10.3390/jcm13010150
BibTeX
@article{Uccello2023,
author = {Uccello, Giuseppe and Bonacchi, Giacomo and Rossi, Valentina Alice and Montrasio, Giulia and Beltrami, Matteo},
title = {Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {13},
number = {1},
pages = {150},
doi = {10.3390/jcm13010150}
}
EUVIMED